GHRP-2 and MK-677 Interaction
GHRP-2 and MK-677 have a synergistic interaction with 95% confidence. MK-677 baseline elevation combines with GHRP-2 pulsatile spikes. Both compounds affect the gi tract and pituitary, so monitoring these systems is recommended.
Compound Profiles
GHRP-2
Growth Hormone Releasing Peptide-2 | Pralmorelin
GHRP-2 acts as a synthetic agonist of ghrelin, binding to the growth hormone secretagogue receptor (GHS-R1a) in the hypothalamus and pituitary. This stimulates cAMP production and promotes pulsatile release of endogenous growth hormone without suppressing natural feedback loops.
View full profileMK-677
Ghrelin Receptor Agonist | Oral Growth Hormone Secretagogue
Selectively binds GHS-R1a receptors in hypothalamus and pituitary, triggering pulsatile growth hormone release while maintaining natural circadian patterns..
View full profileCombined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take GHRP-2 with MK-677?
Yes, GHRP-2 and MK-677 can generally be taken together. MK-677 baseline elevation combines with GHRP-2 pulsatile spikes.
Is GHRP-2 and MK-677 safe together?
Based on documented research, this combination is considered synergistic. However, shared safety flags include: carcinogenic risk, insulin disrupting, teratogenic. Monitor accordingly.
What are the interactions between GHRP-2 and MK-677?
MK-677 baseline elevation combines with GHRP-2 pulsatile spikes. This assessment has 95% confidence and is based on documented research data.
How should I time GHRP-2 and MK-677?
GHRP-2 has a half-life of ~30 minutes and MK-677 has a half-life of ~24 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.